病院薬学
Online ISSN : 2185-9477
Print ISSN : 0389-9098
ISSN-L : 0389-9098
テオフィリン徐放性シロップ製剤の調剤および服薬時における留意点
一澤 正之佐々木 郁子岩田 政則瀧澤 武雄城武 昇一
著者情報
ジャーナル フリー

1995 年 21 巻 2 号 p. 109-114

詳細
抄録
THEODUR®syrup (TDRsyr) is the first liquid dosage form of a long-acting theophylline in Japan. The dosage form design, a matrix form containing theophylline, is suspended in Dsorbitol solution having a high viscosity. To ensure its efficacy, it is necessary to develop precise dispensing technigue. The content of theophylline in TDRsyr was measured by highperformance liquid chromatography (HPLC) after methanol extraction. The concentration of theophylline, after being shaken in a container of TDRsyr (20mg/ml), was 101.5w/v% of the indication value. And its coefficient of variation was 0.7%(n=5), conforming that the quantitative method has good reproducibility. For reliable dispensing, shaking the commercial TDRsyr for longer than 40 minutes is required, and shaking must be done in an up-and-down manner 8 times (8 cycles) per second. Moreover, prior taking it as a dosage, it must be shaken for longer than 2 minutes for 4 cycles per second. When a patient measures out the TDRsyr dosage, a measuring cup is found to be more suitable for reliable dispensing than a small pipette.
著者関連情報
© 一般社団法人 日本医療薬学会
前の記事 次の記事
feedback
Top